giotrif 30 mg 28 f.c. tabs
جيوتريف 30 مجم 28 قرص
afatinibThe published official price. Pharmacies may differ slightly.
- Strength
- 30 mg
- Form
- tablet
- Manufacturer
- boehringer ingelheim > egyptian pharmaceutical trading company
- Route
- oral.solid
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Indicated for certain EGFR mutation-positive metastatic non-small cell lung cancers and for metastatic squamous NSCLC after platinum-based chemotherapy.
Do not use if
No specific absolute contraindications are listed, but hypersensitivity to the drug requires discontinuation.
Side effects
Common adverse effects include diarrhea, rash, skin reactions, mouth inflammation, and nail disorders. Serious pulmonary, hepatic, and gastrointestinal complications may occur.
Warnings
Monitor for severe diarrhea, skin toxicity, interstitial lung disease, hepatic injury, and dehydration.
How it works
An irreversible ErbB family tyrosine kinase inhibitor that blocks EGFR, HER2, and HER4 signaling pathways.
Storage
Store at 20–25°C in the original container protected from moisture.